Skip to main content
Erschienen in: Reactions Weekly 1/2019

01.02.2019 | Case report

Nivolumab/immunosuppressants

Panuveitis with serous retinal detachment and increased liver metastases: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Wang W, et al. Recurrent grade 4 panuveitis with serous retinal detachment related to nivolumab treatment in a patient with metastatic renal cell carcinoma. Cancer Immunology Immunotherapy 68: 85-95, No. 1, 25 Jan 2019. Available from: URL: http://doi.org/10.1007/s00262-018-2260-7 - China Wang W, et al. Recurrent grade 4 panuveitis with serous retinal detachment related to nivolumab treatment in a patient with metastatic renal cell carcinoma. Cancer Immunology Immunotherapy 68: 85-95, No. 1, 25 Jan 2019. Available from: URL: http://​doi.​org/​10.​1007/​s00262-018-2260-7 - China
Metadaten
Titel
Nivolumab/immunosuppressants
Panuveitis with serous retinal detachment and increased liver metastases: case report
Publikationsdatum
01.02.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-57834-6

Weitere Artikel der Ausgabe 1/2019

Reactions Weekly 1/2019 Zur Ausgabe

Case report

Lenalidomide

Case report

Amphotericin B